110 related articles for article (PubMed ID: 12372926)
21. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
[TBL] [Abstract][Full Text] [Related]
22. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
23. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.
Scuteri A; Tesauro M; Rizza S; Iantorno M; Federici M; Lauro D; Campia U; Turriziani M; Fusco A; Cocciolillo G; Lauro R
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):349-56. PubMed ID: 17935958
[TBL] [Abstract][Full Text] [Related]
24. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
25. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
[TBL] [Abstract][Full Text] [Related]
26. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
27. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
28. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
29. Effect of general and epidural anesthesia on hemostasis and fibrinolysis in hepatic patients.
Khafagy HF; Hussein NA; Radwan KG; Refaat AI; Hafez HS; Essawy FM; Kamel HH
Hematology; 2010 Oct; 15(5):360-7. PubMed ID: 20863432
[TBL] [Abstract][Full Text] [Related]
30. Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.
Bulava A; Slavík L; Fiala M; Heinc P; Skvarilova M; Lukl J; Krcová V; Indrák K
J Interv Card Electrophysiol; 2004 Jun; 10(3):271-9. PubMed ID: 15133367
[TBL] [Abstract][Full Text] [Related]
31. The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus.
Guldiken S; Turgut B; Demir M; Arikan E; Kara M; Vural O; Tugrul A; Fareed J
Clin Appl Thromb Hemost; 2006 Jan; 12(1):55-60. PubMed ID: 16444435
[TBL] [Abstract][Full Text] [Related]
32. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
Vene N; Mavri A; Kosmelj K; Stegnar M
Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
[TBL] [Abstract][Full Text] [Related]
33. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
[TBL] [Abstract][Full Text] [Related]
34. Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
Mills JD; Mansfield MW; Grant PJ
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):704-9. PubMed ID: 11950714
[TBL] [Abstract][Full Text] [Related]
35. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects.
Kario K; Matsuo T; Kobayashi H; Hoshide S; Shimada K
J Am Coll Cardiol; 2001 Mar; 37(3):871-7. PubMed ID: 11693764
[TBL] [Abstract][Full Text] [Related]
36. Plasma Fibrinolysis Parameters in Smokers and Non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Delgado GE; Siekmeier R; Krämer BK; März W; Kleber ME
Adv Exp Med Biol; 2015; 858():69-77. PubMed ID: 25786403
[TBL] [Abstract][Full Text] [Related]
37. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus.
Kuzhandai velu V; Jyothirmayi B; Kumar JS
Diabetes Metab Syndr; 2011; 5(3):143-7. PubMed ID: 22813567
[TBL] [Abstract][Full Text] [Related]
39. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
